home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post navigation
Previous Post
Previous
C4 Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating CFT1946, an Orally Bioavailable BiDAC™ Degrader, in BRAF V600 Mutant Solid Tumors
Next Post
Next
Cullinan Oncology to Participate in the Guggenheim 5th Annual Oncology Conference and the SVB Securities Global Biopharma Conference